SilcsBio Awarded $1,760,531 in SBIR Phase II Funding from the National Institutes of Health
SilcsBio will leverage the award to extend its commercially available software from small molecule design to the design of biological therapeutics November 16, 2021, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced it has been awarded a $1,760,531 Small [...]
Aikido Provides Update on Use of Machine Learning in Drug Development Program
FOR IMMEDIATE RELEASE: Aikido Provides Update on Use of Machine Learning in Drug Development Program NEW YORK, NY August , 2021 /PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided and update on the use of Machine Learning in support of its antiviral platform with the University [...]
Job Opening: Scientific Programmer
SilcsBio's parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio. Immediate Job Opening Scientific Programmer July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are [...]
Job Opening: Machine Learning, Deep Tech Applications
SilcsBio's parent company, Early Charm, has a job opening to work with SilcsBio and other portfolio companies focused on Drug Design and Machine Vision. Immediate Job Opening Machine Learning Deep Tech Applications July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that [...]
Job Opening: Full-Stack Developer, Deep Tech Applications
SilcsBio's parent company, Early Charm, has a job opening to work with SilcsBio and other portfolio companies focused on Drug Design and Machine Vision. Immediate Job Opening Full-Stack Developer Deep Tech Applications July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that [...]
SilcsBio is Selected by the NIH to 2021 BIO Digital’s Innovation Zone, June 10-11 and 14-18
FOR IMMEDIATE RELEASE: SilcsBio is Selected by the NIH to 2021 BIO Digital’s Innovation Zone, June 10-11 and 14-18 SilcsBio’s Sunhwan Jo to attend BIO Digital with focus on SilcsBio's expertise in fragment-based drug design, MD simulations, and computational drug discovery June 8, 2021, Baltimore, MD – SilcsBio, [...]
